Sinovac Biotech releases results of 2015 Annual General Meeting of Shareholders held in Beijing, PRC

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC. The required quorum, a majority of the common shares outstanding, was voted by proxy.

The Company's shareholders approved the following proposals:

• The re-election of Weidong Yin, Yuk Lam Lo, Simon Anderson, Kenneth Lee and Meng Mei as the Company's directors until the next annual meeting of shareholders and or until their successors are duly elected;
• The audited consolidated financial statements of the Company for the financial year ended December 31, 2014 together with the Report of Independent Registered Public Accounting Firm thereon and the notes thereto;
• The appointment of Ernst & Young Hua Ming LLP as the independent auditor of the Company for the fiscal year ending December 31, 2015 and to authorize the directors of the Company to fix such independent auditor's remuneration.